JOHN B GREEN Insider Trading $GTCB rEVO Biologics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN B GREEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN B GREEN. JOHN B GREEN is Senior Vice President and CFO in rEVO Biologics, Inc. ($GTCB) and Senior VP and CFO in rEVO Biologics, Inc. ($GTCB) and SVP and CFO in rEVO Biologics, Inc. ($GTCB) and Chief Financial Officer in Dicerna Pharmaceuticals Inc ($DRNA) and Chief Financial Officer in Verastem, Inc. ($VSTM).
JOHN B GREEN in rEVO Biologics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN B GREEN: Senior VP and CFO, SVP and CFO, Senior Vice President and CFO
Holdings: 28,173 shares
Latest Transaction: Nov 04 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN B GREEN in rEVO Biologics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DRNA, GTCB, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 1.21 | 13,722 | 16,604 | 28,173 | 14.5 K to 28.2 K (+94.96 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Payment of Exercise | F | 2.66 | 1,165 | 3,099 | 14,451 | 15.6 K to 14.5 K (-7.46 %) |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 0.37 | 35,000 | 12,950 | 35,000 | |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 5,400 | 0 | 156,170 | 150.8 K to 156.2 K (+3.58 %) |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 0.31 | 100,000 | 31,000 | 100,000 | |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 30,600 | 0 | 150,700 | 120.1 K to 150.7 K (+25.48 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 0.63 | 25,000 | 15,750 | 25,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 32,970 | 0 | 120,170 | 87.2 K to 120.2 K (+37.81 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Buy | P | 0.89 | 1,500 | 1,334 | 87,200 | 85.7 K to 87.2 K (+1.75 %) |
| Jun 01 2007 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 1.18 | 22,500 | 26,550 | 22,500 | |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 1.04 | 45,000 | 46,800 | 45,000 | |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 1.23 | 1,000 | 1,230 | 85,700 | 84.7 K to 85.7 K (+1.18 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 1.03 | 35,000 | 36,050 | 35,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 41,821 | 0 | 84,700 | 42.9 K to 84.7 K (+97.53 %) |
| May 16 2005 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Buy | P | 1.39 | 1,000 | 1,390 | 42,879 | 41.9 K to 42.9 K (+2.39 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Option Exercise | A | 1.71 | 39,000 | 66,690 | 39,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Grant | A | 0.00 | 6,750 | 0 | 41,879 | 35.1 K to 41.9 K (+19.21 %) |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior Vice Preside ... | Option Exercise | A | 3.96 | 25,000 | 99,000 | 25,000 |
Page: 1